CARGO Therapeutics, Inc. Intellectual Property Contracts & Agreements
10 Contracts & Agreements
- License Agreements (10 contracts)
- Patent License Agreement, dated February 24, 2023, by and between the Registrant and the National Cancer Institute (Filed With SEC on November 6, 2023)
- Patent License Agreement, dated March 16, 2022, by and between the Registrant and the National Cancer Institute (Filed With SEC on November 6, 2023)
- License and Supply Agreement, dated June 24, 2022, by and between the Registrant and Oxford Biomedica (UK) Limited (Filed With SEC on November 6, 2023)
- Amendment No. 1 to Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (Filed With SEC on November 6, 2023)
- Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (Filed With SEC on November 6, 2023)
- License and Supply Agreement, dated June 24, 2022, by and between the Registrant and Oxford Biomedica (UK) Limited (Filed With SEC on November 1, 2023)
- Patent License Agreement, dated February 24, 2023, by and between the Registrant and the National Cancer Institute (Filed With SEC on October 20, 2023)
- Patent License Agreement, dated March 16, 2022, by and between the Registrant and the National Cancer Institute (Filed With SEC on October 20, 2023)
- Amendment No. 1 to Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (Filed With SEC on October 20, 2023)
- Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (Filed With SEC on October 20, 2023)
